Brief: Hummingbird Bioscience Licenses Novel Antibodies To Immunome
07/01/2025 13:08
Jan 7 (Reuters) - Immunome Inc IMNM.O :
* HUMMINGBIRD BIOSCIENCE LICENSES NOVEL ANTIBODIES TO
IMMUNOME
Source text: ID:nGNX7JwnGb
Further company coverage: IMNM.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Immunome
See all newsBrief: Immunome - Enters Amendment No. 4 To License Agreement With Bristol-Myers Squibb Company On Oct 2, 2026
US STOCKS ON THE MOVE-Cardinal Health, nVent, Acuity
U.S. STOCKS ON THE MOVE-Cardinal Health, Fervo Energy, Rocket Lab
U.S. STOCKS ON THE MOVE-Progress Software, Vicor Corp, Accenture
Immunome climbs as Stifel initiates coverage